WHO Grade III Gliomas
1 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| Safety and Efficacy Study for DC Vaccine in Recurrent or Progressive High-grade Gliomas (NCT06253234) | Beijing Tiantan Hospital | 2024-02-02 |
Track WHO Grade III Gliomas automatically
Every clearance here is in the API, with alerts when new ones post.